Cerebrovascular Ischemic Events in Patients With Advanced Renal Cell Carcinoma Treated With Anti-Angiogenic Tyrosine Kinase Inhibitors: A Report on Two Cases With Different Outcomes

Journal of Medical Cases

doi 10.14740/jmc2289w

Full Text

Abstract

Available in

Date

Authors

Publisher

Elmer Press, Inc.

Related search

Concomitant Oral Tyrosine Kinase Inhibitors and Bisphosphonates in Advanced Renal Cell Carcinoma With Bone Metastases

British Journal of Cancer
Cancer ResearchOncology
2012English

Renal Dysfunction in Patients With Radioactive Iodine-Refractory Thyroid Cancer Treated With Tyrosine Kinase Inhibitors

Medicine
Medicine
2019English

Cardiotoxicity Monitoring in Patients Treated With Tyrosine Kinase Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

Outcomes of Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy After Immuno-Oncology Checkpoint Inhibitors

European urology oncology
OncologyRadiologyUrologyNuclear MedicineImagingSurgery
2019English

Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial

Oncologist
Cancer ResearchMedicineOncology
2015English

Arterial Events in Patients With Chronic Myeloid Leukemia Receiving Treatment With Second Generation Tyrosine Kinase Inhibitors

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2016English

Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma

Current Oncology
Oncology
2010English

Personalized Therapy in Renal Cell Carcinoma: Are the Different Tyrosine Kinase Inhibitors the Same for Any Patient?

Expert Review of Precision Medicine and Drug Development
Molecular MedicineDrug DiscoveryGeneticsPharmacology
2017English

Mp78-10 the Influence of Genetic Variants on Clinical Outcomes and Toxic Effects in Patients With Advanced Renal Cell Carcinoma Treated With Sorafenib: A Multi-Center Research

Journal of Urology
Urology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy